Condensed Statements of Shareholders' Deficiency - USD ($)	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	1,233,853
Beginning balance	$ (1,034,012)	$ (930,624)
Net loss	$ (24,667)	(22,773)
Ending balance (in shares)	1,233,853
Ending balance	$ (1,058,679)	$ (953,397)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	1,233,853	1,233,853
Beginning balance	$ 1,233	$ 1,233
Ending balance (in shares)	1,233,853	1,233,853
Ending balance	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	81,323	81,323
Ending balance	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(1,116,568)	(1,013,180)
Net loss	(24,667)	(22,773)
Ending balance	$ (1,141,235)	$ (1,035,953)